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Abstract
Background: Sialic acid is a component of many tumor-
associated oligosaccharide antigens. The repertoire of sialic acids
presented by cells can be expanded to include unnatural variants
by intercepting the sialic acid biosynthetic pathway with unnatural
precursors. We explored whether unnatural cell surface sialosides
produced by metabolism can act as neo-antigens and modulate the
immunogenicity of cells.
Results : Immunization of rabbits with synthetic conjugates of
an unnatural sialic acid bound to keyhole limpet hemocyanin
produced significant titers of antibodies that were specific for the
structurally altered sialic acid. The antibodies recognized cells that
were fed the unnatural biosynthetic precursor, and were capable of
directing complement-mediated lysis.
Conclusions: Structural alteration of sialic acids replaces a
tolerized self-antigen with an antigenic determinant. Incorporation
of unnatural sialosides into cell surface glycoconjugates through
biosynthetic means can alter the immunoreactivity of cells,
providing new possibilities for tumor immunotherapy. ß 2001
Elsevier Science Ltd. All rights reserved.
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1. Introduction
Cancer cells have long been known to express glycosyl-
ation patterns that are di¡erent from those found on the
parent cells [1^4]. The structural characterization of these
altered glycoforms has identi¢ed carbohydrate motifs as-
sociated with tumor tissue. Some are truly tumor-speci¢c
antigens that have not been found in normal tissue; other
antigens are present in normal tissue, but over-expressed
on tumor cells, and still others are displayed during fetal
development, disappear in the adult, only to arise again
during malignant transformation [3,5]. Sialic acids are
components of many tumor-associated carbohydrate anti-
gens [6^9]. As occupants of the terminal positions in nu-
merous cell surface oligosaccharide structures, sialic acids
are poised to interact with the immune system, and yet
sialylation of cell surface oligosaccharides can mask
underlying antigenic determinants [10,11]. This suggests
at least one role for the hypersialylation of cell surface
oligosaccharides observed in many forms of malignancy
[12,13]. An unusual feature of sialic acids is their potential
for species-speci¢c structural elaboration by O-acetylation,
O-methylation, N-deacetylation, hydroxylation, phosphor-
ylation, or sulfation [11]. As a consequence, sialylated gly-
coproteins from one species can be antigenic when inocu-
lated into another species, with at least part of the immune
response being directed against the foreign sialoside
[14,15]. Thus, while an organism’s immune system has
been induced to recognize its own sialylated glycoforms
as self, subtle perturbations of the sialic acid structure
can render the sialoforms antigenic.
We and others have shown that the natural diversity of
sialic acids presented by cells can be expanded by inter-
cepting the sialic acid biosynthetic pathway with structur-
ally augmented non-natural biosynthetic substrates [16^
20]. For example, cells can metabolize N-levulinoylman-
nosamine (ManLev) or the more bioavailable acetylated
ManLev (1, Scheme 1) and express N-levulinoylneura-
minic acid (SiaLev, 2) on the cell surface [21,22]. The
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straightforward fashion in which structurally altered sialo-
sides can be presented on cells prompted us to consider
this as a possible mechanism to control their immunoge-
nicity.
Cancer cells, while antigenic, are rarely immunogenic;
they employ numerous mechanisms to evade immune de-
tection during growth, engendering tolerance by the im-
mune system [23,24]. Many attempts at generating anti-
cancer vaccines have focused on breaking the immune
tolerance for tumor-associated carbohydrate antigens
[25^27]. An important theme that has arisen from these
studies is the necessity of formulating the vaccine such that
the antigen is presented to the immune system outside the
context of the tumor. Synthetic antigens composed of mul-
tiple copies of a tumor-associated antigen bound to a non-
self carrier protein have been shown to generate a high-
titer antibody response against the carbohydrate antigen
presented on the malignant cells [27,28]. In addition to its
function as a sca¡old for oligosaccharide presentation, the
carrier protein also provides a T-cell stimulatory epitope
which is necessary for the development of a complete im-
mune response [29,30]. Chemical modi¢cation of carbohy-
drate structures has also been found to augment the anti-
genicity of oligosaccharide-based vaccines [27,31^34]. For
example, modi¢cation of ganglioside-associated sialic acid
residues by esteri¢cation, amidation, or reduction in-
creases an antibody response [33,34]. However, the im-
mune responses were rather speci¢c, where most of the
antibodies bound only the unnaturally modi¢ed structure
with little cross-reactivity to native structures presented on
tumor cells. While these results were not initially encour-
aging from the practical standpoint of developing e¡ective
anti-cancer vaccines, they suggest that introducing unnatu-
ral modi¢cations into carbohydrate structures on immu-
nogenic carrier proteins can potentiate the immune re-
sponse against carbohydrate antigens.
Here we demonstrate that a synthetic neoglycoprotein
comprising multiple copies of SiaLev conjugated to key-
hole limpet hemocyanin (KLH, 3), an immunogenic car-
rier protein, is highly antigenic in rabbits (Scheme 1). Spe-
ci¢c, sustained, high-titer antibody responses directed
against the SiaLev epitopes were induced following immu-
nization with the neoglycoprotein. Cells treated with nano-
molar to micromolar concentrations of acetylated ManLev
were rendered highly reactive with the sera derived from
these rabbits. The SiaLev induced on cells treated with
acetylated ManLev was stable to aldehyde ¢xation, allow-
ing characterization of the intracellular distribution of
these unnatural glycoforms. Finally, we discovered that
the immunogenicity of cells can be controlled with acety-
lated ManLev, as cells expressing the neo-antigen SiaLev
were selectively lysed upon treatment with the anti-SiaLev
Scheme 1. A strategy for inducing immune recognition of cell surfaces based on unnatural sialic acid biosynthesis. Rabbits are immunized with unnatu-
ral sialic acids conjugated to keyhole limpet hemocyanin (3). Cells are induced to express SiaLev (2) as a component of their cell surface glycoconju-
gates by treatment with the metabolic precursor acetylated ManLev (1). Sera from the immunized rabbits are highly reactive only with SiaLev-express-
ing cells, while cells expressing natural sialosides are not reactive with the sera.
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serum and complement. The ability to modulate the cell
surface expression of SiaLev, and recruit immune system
components to cells expressing this neo-antigen, suggests a
new approach to immunotherapy based on unnatural
sialic acid biosynthesis.
2. Results and discussion
2.1. Synthesis of antigens
The SiaLev^KLH antigen (3, Scheme 1) was synthesized
as shown in Fig. 1. The allyl glycoside 5 was synthesized in
three steps as previously described [35] from N-acetylneur-
aminic acid (4). In order to introduce the desired levuli-
noyl group as the N-acyl substituent, the N-acetamido
group in compound 5 was converted to the acyl carbamate
6. Treatment of compound 6 with catalytic sodium meth-
oxide in methanol removed all acetyl groups, a¡ording
carbamate 7. The amino group at C5 in 7 was liberated
by treatment with tri£uoroacetic acid (TFA), and imme-
diately reacted with a mixed carbonic anhydride of levu-
linic acid (8) to yield compound 9. The methyl ester was
then saponi¢ed and the glycosidic O-allyl group was pho-
tochemically reacted with thioethanolamine to a¡ord
amine 10. This unnatural sialic acid hapten was conju-
gated to the KLH by conversion of the free amino group
to the isothiocyanate, followed by reaction with a concen-
trated solution of KLH to provide conjugate 3. Approx-
imately 60^70% of available lysines were modi¢ed with the
epitope, resulting in roughly 160^190 SiaLev residues per
molecule of KLH. Using the same procedure SiaLev was
also conjugated to bovine serum albumin (BSA) for use in
ELISAs.
2.2. Immunizations
Two New Zealand White rabbits were immunized and
given boosts at regular intervals with the SiaLev^KLH
conjugate. After each boost, whole serum was analyzed
by ELISA using SiaLev^BSA as a substrate (Fig. 2a).
The sera contained a signi¢cant titer of antibodies speci¢c
for the unnatural sialic acid. Importantly, no cross-reac-
tivity was observed with native sialic acid in the form of a
SiaK(2C3)GalL(1C4)GlcNAc^BSA (SiaLacNAc^BSA)
conjugate. The titer of SiaLev-speci¢c antibodies evoked
following each boost of antigen was similar in both ani-
mals following repeated immunization (Fig. 2b). In addi-
tion, subtyping analysis revealed that a majority of the
antigen-speci¢c antibodies were of the IgG rather than
the IgM subclass (data not shown), indicative of the re-
cruitment of T-cell help in the induction of the immune
response [27,36]. Thus, the SiaLev^KLH antigen used in
this study appears to recruit the T-cell help required for a
speci¢c, potent immune response against an epitope (Sia-
Lev) structurally similar to an abundant and ubiquitous
self-antigen (sialic acid).
2.3. Antigenicity of cell surfaces
As demonstrated above, immunizations with SiaLev^
KLH produced antibodies that bind immobilized SiaLev
on a microtiter plate. We next evaluated whether the anti-
bodies recognized SiaLev expressed within cell surface gly-
Fig. 1. Synthesis of SiaLev^KLH (3). (a) (i) MeOH, TFA; (ii) acetyl chloride, HCl; (iii) AgClO4, allyl alcohol, 4 Aî molecular sieves: 56% over three
steps. (b) Di-tert-butyl dicarbonate, DMAP, TEA, THF: 57%. (c) NaOMe/MeOH: 93%. (d) (i) 10% TFA in CH2Cl2 ; (ii) NaOMe, 8, methanol: 40%
over two steps. (e) (i) NaOH; (ii) 2-aminoethanethiol hydrochloride, 254 nm light: 60% over two steps. (f) (i) thiophosgene, Na2CO3, 1:1 H2O/CHCl3 ;
(ii) carrier protein (KLH or BSA), 300 mM NaHCO3, pH 9: 60^70% of available lysines were conjugated.
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coconjugates. Native sialic acid is found as a terminal
sugar on both N- and O-linked glycoproteins, as well as
glycolipids [37]. For these reasons, we chose to examine
the reactivity of cell surfaces from cell lines known to
present sialic acids in a variety of glycosylation environ-
ments. The three cell lines examined in this study were
HeLa cells, which display both N- and O-linked sialogly-
coproteins, Jurkat cells, which express sialic acid mainly in
N-linked glycoproteins, and HL-60 cells, which display an
abundance of O-linked sialoglycoproteins [21,38,39].
HeLa cells were cultured for 3 days in medium supple-
mented with 30 WM acetylated ManLev, washed and then
labeled with diluted sera raised against SiaLev^KLH, and
¢nally stained with a FITC-labeled secondary (anti-rabbit
Ig) antibody. The degree of cell surface staining was as-
sessed by £ow cytometry (Fig. 3a). HeLa cells cultured in
the presence of acetylated ManLev exhibited no detectable
reactivity with pre-immunization sera from the animals.
Likewise, HeLa cells treated with dilutions of anti-SiaLev
sera (1:200) exhibited only background £uorescence stain-
ing when grown in medium without acetylated ManLev.
However, cells that had been cultured in the presence of
acetylated ManLev exhibited a marked increase in the im-
munoreactivity with anti-SiaLev sera. Similar results were
observed with Jurkat and HL-60 cells (data not shown). In
addition, the cell surface immunoreactivity of antisera pro-
Fig. 2. Reactivity of rabbit antisera with SiaLev as determined by ELI-
SA. (a) Reactivity of whole sera with SiaLev and SiaLacNAc. (b) Titer
of sera from di¡erent rabbits following each antigen boost. Titer is de-
¢ned as the dilution of serum which yields an optical density of half
saturation in a set of serial dilutions such as that shown in (a).
Fig. 3. Surface reactivity of live cells with SiaLev antisera assessed by
£ow cytometry. (a) Characteristic cell surface reactivity of cells deter-
mined by £ow cytometry. Red: HeLa cells cultured with 30 WM acety-
lated ManLev (Ac4ManLev) for 3 days, reacted with SiaLev antiserum,
and RG-16-FITC (monoclonal mouse anti-rabbit Ig-FITC). Dark blue:
HeLa cells cultured with 30 WM acetylated ManLev for 3 days, reacted
with pre-immune serum from the same rabbit that produced the SiaLev
antiserum, and RG-16-FITC. Light blue: HeLa cells cultured without
ManLev, reacted with whole SiaLev antisera, and RG-16-FITC. (b) Cell
surface reactivity of Jurkat cells cultured with di¡erent doses of acety-
lated ManLev (0^30 WM) and reacted with serial dilutions of sera
(1:600^1:19 200). Reported are the mean £uorescence intensities, ex-
pressed in arbitrary units (AU), of populations of 104 cells. Error bars
represent the high and low values of duplicate experiments.
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duced from successive boosts mirrored the titers observed
by ELISA. The reactivity of the antisera with HeLa, HL-
60, and Jurkat cell surfaces appeared to be insensitive to
the di¡erent environments of their various sialosides.
These results imply that the reactive antibodies in the
sera are speci¢c for the SiaLev epitope and are ignorant
of both the linkage and type of glycoconjugate in which it
is expressed.
The extent of antibody binding to SiaLev-expressing
Jurkat cells was found to depend on both the amount of
antibody added to a cell population and the concentration
of acetylated ManLev present in the growth medium (Fig.
3b). Signi¢cant labeling of the cells was observed even
when concentrations of acetylated ManLev were quite
low (1 WM). Cells treated with higher concentrations of
acetylated ManLev exhibited an extremely high amount
of immunoreactivity, such that the antigen available for
immunoreaction on the cell surface was apparently in ex-
cess of the antibody titer present in solution.
In order to determine the selectivity of the antiserum for
SiaLev over other modi¢ed sialic acids, we treated HeLa
cells with acetylated N-pentanoylmannosamine (Man-
Pent), which di¡ers from acetylated ManLev only by re-
placement of the carbonyl with a methylene group, and is
known to be metabolized to cell surface sialosides [40].
Whole serum from four successive bleeds from both ani-
mals was analyzed for its capacity to bind cells treated
with 30 WM acetylated ManNAc, ManPent, or ManLev
(Fig. 4). The sera of rabbit 1 appeared to be entirely spe-
ci¢c for SiaLev, as the SiaPent-expressing cells exhibited
only background reactivity. However, the sera from rabbit
2 did exhibit minimal cross-reactivity with SiaPent-ex-
pressing cells which appeared to decrease with progressive
antigen boosts, perhaps the result of a⁄nity maturation.
These results show that the sialic acid binding antibodies
in the whole serum are speci¢c for SiaLev.
2.4. Cellular distribution of SiaLev
In addition to the surface expression of SiaLev assessed
by £ow cytometry, we investigated the intracellular expres-
sion of SiaLev residues using a⁄nity-puri¢ed SiaLev anti-
sera. Serum that had been pre-cleared by passage through
a sialic acid^agarose resin was applied to a SiaLev^aga-
rose column. The immunoglobulins that bound the Sia-
Lev^agarose resin were eluted, and used in the detection
of intracellular SiaLev residues by £uorescence microsco-
py. HeLa cells cultured on glass coverslips were ¢xed,
permeabilized, and stained with the a⁄nity-puri¢ed sera
(or a control antibody) followed by a £uorophore-labeled
secondary antibody. The coverslips were then mounted on
slides in a mounting medium containing DAPI, a DNA-
speci¢c stain [41] used to image the nuclei. Slides were
Fig. 4. SiaLev antiserum reactivity with cells treated with di¡erent sialic
acid biosynthetic precursors. Mean £uorescence intensities were deter-
mined by £ow cytometry analysis of HeLa cells cultured for 3 days with
30 WM acetylated ManNAc (green), ManPent (red), ManLev (blue), or
no biosynthetic precursor (black). The cells were then washed and
stained with sera from di¡erent immunized rabbits (R) collected after
each antigen boost (B), followed by treatment with RG-16-FITC. Error
bars represent the high and low values of duplicate experiments.
Fig. 5. Intracellular localization of SiaLev in ¢xed and permeabilized
HeLa cells. (a) Cells cultured with 30 WM acetylated ManLev, stained
with a⁄nity-puri¢ed SiaLev antiserum, goat anti-rabbit IgG (H+L)-
Alexa0Fluor1-488, and DAPI. (b) Cells cultured without acetylated
ManLev, otherwise treated as in panel a. (c) Cells cultured with 30 WM
acetylated ManNAc but without acetylated ManLev, otherwise treated
as in panel a. (d) Cells cultured with 30 WM acetylated ManLev, treated
with non-speci¢c rabbit IgG, goat anti-rabbit IgG (H+L)-Alexa0-
Fluor1-488, and DAPI. Images shown are single 2 Wm thick optical
sections at 1000U magni¢cation in a plane through the center of the
nuclei. Scale bars represent 10 Wm.
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imaged by two-color laser scanning confocal microscopy
(Fig. 5). An extensive continuum of SiaLev-containing
vesicles leading from the Golgi (proximal to the nucleus)
to the plasma membrane was revealed using the SiaLev-
speci¢c sera (Fig. 5a). By contrast, control cells treated
with bu¡er (Fig. 5b), with acetylated ManNAc (Fig. 5c),
or with non-speci¢c rabbit IgG (Fig. 5d) showed no vesic-
ular or plasma membrane staining. Thus, the processing of
unnatural sialic acids through the secretory pathway can
be tracked using speci¢c antisera.
2.5. Immunogenicity of cell surface SiaLev
Finally, we investigated the ability to transform cell
surfaces via unnatural sialic acid metabolism as a means
of targeting cells for immune destruction. A major e¡ector
function of antibody binding to cell surfaces is the activa-
tion of complement against foreign particles or cells [42].
We investigated the activity of the antisera in stimulating
antibody-dependent, complement-mediated cytolysis of
cells that were induced to express SiaLev. Jurkat cells
were cultured in media supplemented with 20 WM acety-
lated ManLev, 20 WM acetylated ManNAc, or no supple-
ment. The cells were harvested and treated with a⁄nity-
puri¢ed anti-SiaLev serum or non-speci¢c rabbit IgG as a
control. Cells were then treated with rabbit serum comple-
ment or heat-inactivated complement as a control. Over
98% of cells that were treated with acetylated ManLev,
anti-SiaLev serum, and complement were lysed in this as-
say (Fig. 6a). Removal of the antigen-speci¢c sera or re-
placement with non-speci¢c IgG induced only background
lysis of these cells (15^20%). The background lysis was due
to non-speci¢c activity of complement, as heat-inactivating
the complement prior to cell treatment nulli¢ed this e¡ect.
Lysis of the Jurkat cells was also dependent on their prior
exposure to acetylated ManLev since the cell populations
that were untreated or exposed to acetylated ManNAc
exhibited only background levels of cytolysis (15^20%).
These results demonstrate that SiaLev antiserum is a po-
tent mediator of complement-dependent cytolysis and is
selective for cells expressing the neo-antigen SiaLev.
The extent of complement-mediated lysis of Jurkat cells
was found to depend on the dose of acetylated ManLev
the cells were exposed to (Fig. 6b), presumably due to the
resultant di¡erences in cell surface antigen density. Max-
imal lysis was achieved when cells were cultured with con-
centrations of acetylated ManLev of 9 WM or higher in the
medium. At concentrations below 300 nM, there was no
detectable antibody-mediated, complement-dependent lysis
of Jurkat cells. These results are consistent with data pre-
sented in this paper and previously that the surface density
of the unnatural sialosides is controlled by the amount of
unnatural mannosamine made available to the cell [21]. At
exogenous concentrations of acetylated ManLev above
9 WM, the antigen induced on the cells was apparently in
excess of that needed to recruit su⁄cient immunoglobulin
for complement activation. Thus, the ability to vary the
SiaLev density on target cells provides a mechanism for
modulating immunogenicity using unnatural metabolic
precursors.
The speci¢city of the immune response for tumor cell
surfaces may be increased if an animal is vaccinated with
the SiaLev epitope as a part of a tumor-associated carbo-
hydrate antigen. For example, vaccination with a carbo-
hydrate antigen which incorporates SiaLev as a part of a
larger carbohydrate structure should induce an immune
Fig. 6. Antibody-dependent, complement-mediated lysis of SiaLev-ex-
pressing cells. (a) Jurkat cells were cultured with 20 WM acetylated Man-
Lev (Ac4ManLev), 20 WM acetylated ManNAc (Ac4ManNAc), or with
no supplement, then treated with: SiaLev antiserum and 2.5% rabbit se-
rum complement (dark blue), non-speci¢c rabbit IgG and 2.5% rabbit
serum complement (red), 2.5% rabbit serum complement only (green),
or SiaLev antiserum and 2.5% heat-inactivated rabbit serum comple-
ment (light blue). Percent cytolysis was measured as described in Section
4. (b) Jurkat cells were cultured with varying concentrations of acety-
lated ManLev (0.03^30 WM) over 3 days, then treated with either SiaLev
antiserum and 2.5% rabbit serum complement or non-speci¢c rabbit
IgG and 2.5% rabbit serum complement. Values for percent cytolysis in
both panels a and b are the average of triplicate experiments þ S.D.
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response against the antigen containing SiaLev. Upon ad-
ministration of acetylated ManLev, the expression of the
SiaLev-bearing tumor antigen would be induced, directing
immune recognition of the tumor cells expressing the neo-
antigen. Recently, Liu and coworkers have reported a re-
lated strategy to target leukemic cells expressing polysialic
acid for immune destruction [43]. Notably, administration
of a monoclonal antibody which recognizes poly-N-prop-
anoyl sialic acid prevented metastasis of a leukemic cell
line when the mice were treated with N-propanoylmannos-
amine, a biosynthetic precursor of poly-N-propanoyl sialic
acid.
3. Signi¢cance
While tumor cells are often characterized by unusual
cell surface oligosaccharides, these modi¢cations usually
fail to stimulate an immune response against the cell. In
order to e¡ect such a response, immune self-tolerance to
structures presented on the surface of cancer cells must be
broken. Chemical alteration of tumor antigens has been
shown to augment the antigenicity of these structures
when they are coupled to an appropriate T-cell antigenic
epitope. We have shown that immunization of rabbits with
an unnatural sialic acid antigen, SiaLev^KLH, leads to the
production of signi¢cant titers of antibodies following
each boost. The antibodies recognized SiaLev to the ex-
clusion of the naturally occurring N-acetyl sialic acid.
Cells treated with acetylated ManLev exhibited a strong
reaction with the SiaLev antisera derived from the rabbit
immunization, the extent of which was dependent on the
dose of exogenous acetylated ManLev and the amount of
immunoglobulin added to cells. The antibodies were capa-
ble of stimulating complement-mediated lysis of cells on
which SiaLev expression had been induced. Therefore, this
work represents a way of breaking immune tolerance for
self-antigens, and may have applications in the immuno-
therapy of cancer given the presence of sialic acid in many
tumor-associated carbohydrate antigens.
4. Materials and methods
4.1. Materials
All reagents used in chemical syntheses were obtained from
commercial suppliers and used without further puri¢cation unless
otherwise noted. BSA, KLH, NaN3, diethanolamine, glutaralde-
hyde (EM grade), mouse anti-rabbit Ig (clone RG-16; FITC,
alkaline phosphatase conjugates), rabbit IgG, RPMI 1640 me-
dium, DME medium, penicillin/streptomycin solution (P/S), 1,4-
diazabicyclo(2.2.2)octane (DABCO), and saponin were from Sig-
ma. Trinitrobenzenesulfonic acid and p-nitrophenyl phosphate
were from Pierce. SialylK(2C3)N-acetyllactosamine^BSA and
rabbit serum complement were from Calbiochem. A⁄gel 1020
(4% cross-linked aminoalkyl agarose) was from Bio-Rad. Tryp-
sin^EDTA solution was from Gibco BRL. Fetal calf serum
(FCS) was from Hyclone. Cytotox-961 colorimetric cytotoxicity
assay kit was from Promega. Alexa0Fluor1-488-conjugated goat
anti-rabbit IgG (H+L) and 4P,6-diamidino-2-phenylindole
(DAPI) were purchased from Molecular Probes. p-Formaldehyde
(16% solution, EM grade) was purchased from Electron Micros-
copy Sciences. NMR spectra were recorded on Bruker AMX-300
or 400 spectrometers, mass spectral data were obtained at the
University of California, Berkeley Mass Spectrometry Facility,
immuno£uorescent images were obtained on a Zeiss 510 laser
scanning confocal microscope and interpreted using Zeiss LSM
5 software, and £ow cytometry was performed on a Coulter EP-
ICS1 XL-MCL analytical £ow cytometer. Immunizations, ani-
mal maintenance, and serum collection was performed according
to standard company protocol by Covance Development Serv-
ices.
4.2. Chemical synthesis
4.2.1. Methyl 5-N-acetamido-4,7,8,9-tetra-O-acetyl-2-O-allyl-N-
tert-butoxycarbonyl-3,5-dideoxy-K-D-manno-2-nonulopyran-
osonate (6)
Compound 5 (0.700 g, 1.28 mmol), DMAP (0.0312 g, 0.256
mmol), and di-tert-butyl dicarbonate (0.559 g, 2.56 mmol) were
dissolved in anhydrous THF (6 ml). Freshly distilled triethyl-
amine (180 Wl, 1.28 mmol) was added via syringe. The solution
was stirred for 16 h at room temperature, and then concentrated
in vacuo. The resulting syrup was dissolved in 50 ml of CH2Cl2,
washed with 1 M HCl (2U10 ml), and then saturated NaHCO3
(2U5 ml), and dried over Na2SO4. Puri¢cation by column chro-
matography on silica gel eluting with a gradient of hexanes/
EtOAc (10:1 to 5:1) a¡orded 6 as a white foam (0.471 g,
57%): 1H NMR (400 MHz, CDCl3); 4.5:1 mixture of rotational
isomers (major) : N 5.78 (m, 1H), 5.31^5.24 (m, 2H), 5.20 (app d,
J = 17.2 Hz, 1H), 5.07 (m, 2H), 4.82 (app t, J = 10.3 Hz, 1H), 4.63
(app d, J = 10.4 Hz, 1H), 4.27 (app d, J = 12.5 Hz, 1H), 4.22 (dd,
J = 5.1, 14.1 Hz, 1H), 3.99 (dd, J = 5.3, 12.4 Hz, 1H), 3.82 (dd,
J = 4.6, 11.6 Hz, 1H), 3.70 (s, 3H), 2.67 (dd, J = 4.8, 12.7 Hz, 1H),
2.28 (s, 3H), 2.07 (s, 3H), 2.00 (s, 3H), 1.97 (m, 1H), 1.95 (s, 3H),
1.88 (s, 3H), 1.49 (s, 9H); 13C NMR (100 MHz, CDCl3) N 173.6,
170.4, 170.0, 169.8, 168.0, 167.5, 151.7, 133.5, 116.9, 98.3, 84.4,
71.0, 68.5, 66.7, 66.5, 65.5, 61.8, 52.4, 52.2, 39.0, 27.7, 26.5, 21.0,
20.8, 20.7, 20.5; HRMS (FAB+) 638.2648 (M+Li, 638.2636
calc. for C28H41NO15Li).
4.2.2. Methyl 2-O-allyl-5-N-tert-butoxycarbonyl-3,5-dideoxy-K-D-
manno-2-nonulopyranosonate (7)
A solution of compound 6 (0.471 g, 0.746 mmol) in MeOH (25
ml) was treated with a 1 M solution of NaOMe in MeOH (0.5 ml,
0.5 mmol). The solution was stirred overnight, neutralized with
Amberlite IRC-50 (H form), and concentrated to yield 7 (0.291
g, 93%): 1H NMR (300 MHz, CD3OD) N 5.87 (m, 1H), 5.25 (dd,
J = 1.7, 17.2 Hz, 1H), 5.13 (dd, J = 1.5, 10.4 Hz, 1H), 4.30 (m,
1H), 3.98 (m, 1H), 3.79^3.89 (m, 5H), 3.47^3.67 (m, 5H), 2.70
(dd, J = 4.6, 12.9 Hz, 1H), 1.76 (app t, J = 12.3 Hz, 1H), 1.46 (s,
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9H); 13C NMR (100 MHz, CD3OD) N 171.2, 159.6, 135.6, 117.1,
100.0, 81.0, 75.4, 72.7, 70.4, 68.6, 66.3, 64.9, 54.8, 53.5, 41.9, 28.8;
HRMS (FAB+) 428.2121 (M+Li, 428.2108 calc. for
C18H31NO10Li).
4.2.3. Methyl 2-O-allyl-5-N-(4-oxo-pentanoyl)-3,5-dideoxy-K-D-
manno-2-nonulopyranosonate (9)
Carbamate 7 (0.526 g, 1.25 mmol) was dissolved in CH2Cl2 (10
ml) and TFA (1 ml) was added dropwise with stirring. The solu-
tion was stirred for 1 h at room temperature, then concentrated
in vacuo. Trituration with ether (10 ml) provided a white solid
which was dissolved in methanol (5 ml) and treated with sodium
methoxide in methanol (1 M, 1.25 ml, 1.25 mmol). After stirring
for 15 min, carbonic anhydride 8 [21] (1.4 mmol) in THF (4 ml)
was added dropwise. The resultant yellow solution was stirred
overnight, and then concentrated. Silica gel chromatography
(CHCl3/MeOH, 50:1 to 10:1) provided a yellow foam which
was further puri¢ed by reversed-phase HPLC (CH3CN in H2O,
0^20% over 45 min) to a¡ord compound 9 as a white solid (98.6
mg, 40% based on 7) : 1H NMR (400 MHz, D2O) N 5.85 (m, 1H),
5.26 (dd, J = 1.5, 17.3 Hz, 1H), 5.19 (app d, J = 10.4 Hz, 1H), 4.26
(dd, J = 5.7, 12.3 Hz, 1H), 4.01 (dd, J = 6.1, 12.3 Hz, 1H), 3.82^
3.77 (m, 7H), 3.71 (m, 1H), 3.60 (m, 1H), 3.49 (app d, J = 8.8 Hz,
1H), 2.83 (m, 2H), 2.67 (dd, J = 4.6, 12.8 Hz, 1H), 2.47 (m, 2H),
2.16 (s, 3H), 1.76 (app t, J = 12.3 Hz, 1H; 13C NMR (100 MHz,
D2O) N 213.9, 176.2, 170.1, 133.2, 118.61, 98.9, 73.0, 70.7, 68.4,
67.1, 65.9, 63.2, 53.4, 51.8, 29.5, 29.2; HRMS (FAB+) 420.1875
(M+H, 420.1870 calc. for C18H30NO10).
4.2.4. Compound 10
Allyl glycoside 9 (191.5 mg, 0.457 mmol) was dissolved in
aqueous NaOH (1 M, 0.461 ml, 0.461 mmol) and stirred at
room temperature for 4 h. A solution of 2-aminoethanethiol hy-
drochloride (57 mg, 0.50 mmol) in H2O (0.46 ml) was then added,
and the solution was irradiated for 16 h at room temperature
with 254 nm light from an 18 W lamp under a N2 atmosphere.
Puri¢cation of the reaction mixture by reversed-phase HPLC
(acetonitrile in water, 0^20% over 45 min) provided amine 10
(131.6 mg, 60% based on 9) : 1H NMR (400 MHz, D2O) N
3.84^3.75 (m, 3H), 3.71 (app d, J = 9.9 Hz, 1H), 3.66^3.56 (m,
3H), 3.50 (m, 2H), 3.17 (t, J = 6.5 Hz, 2H), 2.81 (m, 4H), 2.67 (dd,
J = 4.7, 12.6 Hz, 1H), 2.60 (app t, J = 8.0 Hz, 2H), 2.47 (m, 2H),
2.16 (s, 3H), 1.80 (m, 2H), 1.58 (app t, J = 12.2 Hz, 1H); 13C
NMR (100 MHz, D2O) N 213.9, 176.3, 173.6, 100.7, 72.7, 71.9,
68.3, 68.1, 63.1, 62.7, 51.9, 40.5, 38.3, 38.1, 29.4, 29.2, 28.9, 28.2,
27.3; HRMS (FAB+) 483.2003 (M+H, 483.2012 calc. for
C19H35N2O10S).
4.3. Preparation of neoglycoconjugates
4.3.1. SiaLev^KLH (3)
Amine 10 (0.030 g, 0.062 mmol) was dissolved in H2O (600 Wl).
Solid Na2CO3 (8.5 mg, 0.068 mmol) and NaHCO3 (10.4 mg,
0.124 mmol) were added, adjusting the solution to pH 9. A so-
lution of thiophosgene (5.9 Wl, 0.078 mmol) in CHCl3 (300 Wl)
was then added to the vigorously stirred solution of compound 10
at room temperature. After 2.5 h, amine 10 was essentially con-
sumed according to TLC (butanol/acetic acid/water; 5:3:2, 10 :
Rf = 0.6, product: Rf = 0.8) and negative ninhydrin staining. The
mixture was concentrated and the crude product was reconsti-
tuted in H2O for direct use in protein conjugation reactions.
An aqueous solution (700 Wl) of the isothiocyanate derived
from 10 (233 Wl, 10 mg, 0.021 mmol) was added to KLH (8
mg) dissolved in 800 Wl of 300 mM NaHCO3 bu¡er (pH 9).
The mixture was incubated for 12 h at room temperature and
then diluted with 2 ml of PBS and dialyzed against 3U1.5 l of
PBS over 24 h. The trinitrobenzene sulfonic acid assay for un-
conjugated lysine residues [44] revealed that 69% of lysine resi-
dues for conjugation were modi¢ed by 10 using this procedure.
On average each KLH molecule was modi¢ed with 180 copies of
the hapten.
4.3.2. SiaLev^BSA
The same procedure used with KLH was applied to BSA, re-
sulting in the modi¢cation of approximately 57% of the available
lysines. On average, each BSA molecule was modi¢ed with 19
copies of SiaLev.
4.3.3. SiaLev^agarose
Aminoalkyl agarose (5 ml, 4% cross-linked, with a reactive
amine concentration of 16.4 Wmol/ml gel) was equilibrated in
300 mM NaHCO3 (pH 9) bu¡er. An aqueous solution of 10
(1.03 ml, 114 Wmol) that had been activated with thiophosgene
was added to the suspension. The suspension was agitated by
gentle rocking over 16 h. The resin was then washed with 100
ml of PBS and used for a⁄nity puri¢cation.
4.3.4. Sialic acid^agarose
The same procedure used to prepare SiaLev^agarose was ap-
plied to sialic acid^agarose.
4.3.5. A⁄nity puri¢cation of polyclonal sera
Whole serum (5 ml) was diluted 1:10 with bu¡er 1 (10 mM
Tris: pH 7.5), and precleared by passage through a Sia^agarose
column (1.5 ml bed volume) three times over 3 h. The £ow-
through was then applied to a SiaLev^agarose column (1 ml
bed volume) three times over 3 h. The column was washed
with 20 bed volumes of bu¡er 1, followed by 20 bed volumes
of bu¡er 1+500 mM NaCl. The SiaLev column was then eluted
with 15 bed volumes of the following: 100 mM glycine (pH 2.5),
10 mM Tris (pH 8.8), and 100 mM triethylamine (pH 11.5, pre-
pared from freshly distilled triethylamine). All eluates were col-
lected in tubes containing 1.5 bed volumes of 1 M Tris (pH 8.0).
Fractions containing eluate were combined, concentrated, and
dialyzed repeatedly against PBS containing 0.02% NaN3.
4.3.6. Determination of antibody titers by ELISA
Microtiter plate wells (Dynex Immulon II-HB) were coated
with 50 Wg/ml solutions of SiaLev^BSA, or SiaLacNAc^BSA
(50 Wl/well) in PBS for 4 h at room temperature, then blocked
with bu¡er 2 (PBS+3% BSA+0.02% NaN3) overnight at 4‡C. The
plates were then washed twice with PBS, and serial dilutions of
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antisera in bu¡er 2 were added to duplicate wells (50 Wl/well), and
incubated for 2 h at room temperature. The plate was washed
twice with PBS, followed by three washes with 25 mM Tris-bu¡-
ered saline (pH 7.5) (TBS). A secondary antibody (mouse anti-
rabbit Ig: clone RG-16)-alkaline phosphatase conjugate diluted
1:1000 in TBS+3% BSA+0.02% NaN3 was added to each well
(50 Wl/well), and incubated at room temperature for 2 h. The
plate was washed four times with TBS, once with bu¡er 3 (10
mM diethanolamine pH 9.6+0.5 mM MgCl2), and a 0.5 mM
solution of p-nitrophenyl phosphate in bu¡er 3 was added (100
Wl/well). The absorbance at 405 nm was then measured. The titer
of antibody in each batch of serum was de¢ned as the dilution of
serum which corresponded to the absorbance at half the maxi-
mum of the titration curve.
4.3.7. Tissue culture/cell culture conditions
Unless otherwise speci¢ed, Jurkat cells were cultured in RPMI
1640 medium supplemented with 10% FCS, 100 U/ml penicillin,
and 0.1 mg/ml streptomycin (P/S); HeLa cells were cultured in
DME medium supplemented with 10% FCS, and P/S. In all cases
cells were cultured under a humidi¢ed atmosphere containing 5%
CO2 at 37‡C. Jurkat cells were seeded at cell densities of 125 000
to 250 000 cells/ml in 10^15 ml of medium in T-25 £asks and
cultured in suspension. HeLa cells were cultured in 110 cm2 tissue
culture polystyrene dishes, seeded at a density of 9000 cells/cm2 in
10 ml of medium, and cultured as adherent monolayers. For £ow
cytometry experiments, adherent HeLa cells were trypsinized with
trypsin^EDTA, and suspended in DME medium prior to antise-
rum treatment. When appropriate, cells were cultured in the pres-
ence of acetylated ManLev, ManNAc, or ManPent by adding the
appropriate volume of a 50^100 mM stock solution of the com-
pound dissolved in 95% ethanol to the medium.
4.3.8. Flow cytometry assay for cell surface binding of SiaLev
antiserum
All steps were performed at 4‡C. Jurkat or HeLa cells (10^
20U106) were washed twice with 10 ml of bu¡er 4 (PBS, pH
7.4, 2% FCS, 0.02% NaN3) and resuspended at a density of
1.5U106cells/ml. The cell suspension was transferred in 200 Wl
aliquots (3U105 cells) to the appropriate well in a 96 well V-
bottomed microtiter plate. The cells were then isolated by centri-
fugation (1200Ug, 4 min), and resuspended in bu¡er 4 (100 Wl)
containing the appropriate type and dilution of serum. The cells
were incubated for 1 h then washed with bu¡er 4 (3U200 Wl), and
resuspended in 150 Wl of bu¡er 4. FITC-labeled mouse anti-rabbit
Ig (clone RG-16) diluted 1:100 in bu¡er 4 was added to each of
the wells in 50 Wl aliquots. The cells were incubated in the dark
for 1 h. The cells were then washed with bu¡er 4 (3U200 Wl),
resuspended in 400 Wl of bu¡er 4, and analyzed by £ow cytomet-
ry.
4.3.9. Immuno£uorescence analysis of intracellular SiaLev
distribution
A suspension of HeLa cells (1U106/ml) produced as described
above that had been cultured for 2 days in medium supplemented
with or without acetylated sugars was added in 200 Wl aliquots
(200 000 cells/well) to 9.6 cm2 wells which contained glass cover-
slips (22 mm/side) and 5 ml growth medium supplemented with
30 WM of the appropriate acetylated carbohydrate. After 2 days
of growth, the coverslips were washed with PBS (3U5 ml) at
37‡C. Cells were ¢xed on the coverslips at 37‡C for 20 min
then at 4‡C for 15 h in a bu¡er at pH 7.6 containing the follow-
ing: 2% p-formaldehyde, 0.1% glutaraldehyde, 0.1% saponin, and
100 mM KCl, 3 mM MgCl2, 8 mM HEPES, 150 mM sucrose.
Following ¢xation, each coverslip was washed three times with
PBS, pH 7.4, then blocked for 20 min with bu¡er 2. The cover-
slips were then treated with 500 Wl of a 2.5 Wg/ml solution of
a⁄nity-puri¢ed SiaLev antiserum or non-speci¢c rabbit IgG as
a control in bu¡er 2 for 1.25 h, at room temperature with gentle
rocking. The coverslips were then washed three times each with
1.5 ml of bu¡er 2 (10 min incubation/wash). Alexa-488-labeled
goat anti-rabbit IgG (H+L) diluted in bu¡er 2 was applied to
each coverslip (500 Wl, 2 Wg/ml) and incubated in the dark at
room temperature with gentle rocking for 1.25 h. The coverslips
were then washed four times with 1.5 ml of bu¡er 2, followed by
two 1.5 ml washes with PBS. Coverslips were then inverted and
mounted on a drop of mounting medium containing DAPI (90%
glycerol, 10% Tris pH 7.5, 1 Wg/ml DAPI, and DABCO). Slides
were analyzed under oil immersion at 1000U. Images were ob-
tained by dual track imaging using the 488 nm line of a Kr-Ar
laser for excitation with 505 nm LP optics on track 1 and the 364
nm line of an argon ion laser with 435^485 BP optics on track 2.
Images shown are 2 Wm thick single optical sections through the
center of the nuclei and are the result of merging the data from
tracks 1 and 2 which are pseudo-colored green and blue, respec-
tively, in the composite images.
4.3.10. Complement-mediated lysis
Jurkat cells were washed twice with bu¡er 5 (PBS+0.5 mM
MgCl2+0.15 mM CaCl2+5% FCS) and suspended at a density
of 1.5U106 cells/ml in bu¡er 5. Cells were then transferred into
the appropriate wells (160 Wl/well) of a 96 well V-bottomed mi-
crotiter plate which also contained 250 ng of a⁄nity-puri¢ed anti-
SiaLev serum diluted in 40 Wl of bu¡er 5. Cells were incubated at
room temperature for 30 min. Rabbit serum complement diluted
1:4 in bu¡er 5 (50 Wl) was added to each well. For control experi-
ments, the rabbit serum complement was inactivated by heating
at 56‡C for 1 h prior to addition to the cell suspension. The cell
suspension was incubated for 37‡C for 1 h, then centrifuged at
250Ug for 5 min. An aliquot of supernatant (50 Wl) from each
well was transferred to the identically labeled well of a 96 well
£at-bottomed microtiter plate. The amount of lactate dehydroge-
nase (LDH) activity present in each well was quanti¢ed using the
diaphorase/tetrazolium development solution in Promega’s Cyto-
tox-96 cytotoxicity kit according to the manufacturer’s instruc-
tions, followed by measuring the absorbance of each well at 490
nm. The percent lysis was calculated using absorbance values
(average of triplicate samples) according to the following formu-
la: % Cytolysis = (experimental lysis minus spontaneous lysis)/
(maximal lysis minus spontaneous lysis).
Spontaneous lysis was de¢ned as the LDH activity released by
cells treated only with bu¡er 5 during the course of the assay.
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Maximal lysis was de¢ned as the LDH activity of wells in which
cells were treated with 50 Wl of 5% Triton X-100 lysis bu¡er
(Promega) as a substitute for complement.
Acknowledgements
We thank Scarlett Goon for the gift of acetylated N-
pentanoylmannosamine. We are grateful for support from
CaPCURE and the Mizutani Foundation for Glyco-
science. G.A.L. was supported by NIH Biotechnology
Training Grant GM08352. This research was supported
by a grant to C.R.B. from the National Institutes of
Health (RO1 GM58867-01).
References
[1] S. Hakomori, Y. Zhang, Glycosphingolipid antigens and cancer ther-
apy, Chem. Biol. 4 (1997) 97^104.
[2] J.W. Dennis, M. Granovsky, C.E. Warren, Glycoprotein glycosyla-
tion and cancer progression, Biochim. Biophys. Acta 1473 (1999) 21^
34.
[3] M. Fukuda, Possible roles of tumor-associated carbohydrate anti-
gens, Cancer Res. 56 (1996) 2237^2244.
[4] I. Brockhausen, Pathways of O-glycan biosynthesis in cancer cells,
Biochim. Biophys. Acta 1473 (1999) 67^95.
[5] S. Hakomori, Tumor malignancy de¢ned by aberrant glycosylation
and sphingo(glyco)lipid metabolism, Cancer Res. 56 (1996) 5309^
5318.
[6] S. Sell, Cancer-associated carbohydrates identi¢ed by monoclonal
antibodies, Hum. Pathol. 21 (1990) 1003^1019.
[7] S. Kelm, R. Schauer, Sialic acids in molecular and cellular interac-
tions, Int. Rev. Cytol. 175 (1997) 137^240.
[8] A. Varki, Sialic acids as ligands in recognition phenomena, FASEB J.
11 (1997) 248^255.
[9] U. Rutishauser, Polysialic acid at the cell surface: biophysics in serv-
ice of cell interactions and tissue plasticity, J. Cell. Biochem. 70
(1998) 304^312.
[10] L.D. Powell, S.W. Whiteheart, G.W. Hart, Cell surface sialic acid
in£uences tumor cell recognition in the mixed lymphocyte reaction,
J. Immunol. 139 (1987) 262^270.
[11] R. Schauer, Sialic acids as antigenic determinants of complex carbo-
hydrates, Adv. Exp. Med. Biol. 228 (1988) 47^72.
[12] J.G. Collard, J.F. Schijven, A. Bikker, G. LaRiviere, J.G.M. Bolsch-
er, E. Roos, Cell surface sialic acid and the invasive and metastatic
potential of T-cell hybridomas, Cancer Res. 46 (1986) 3521^3527.
[13] R. Takano, E. Muchmore, J.W. Dennis, Sialylation and malignant
potential in tumour cell glycosylation mutants, Glycobiology 4 (1994)
665^674.
[14] J.M. Merrick, K. Zadarlik, F. Milgrom, Characterization of the
Hanganutziu-Deicher (serum sickness) antigen as gangliosides con-
taining N-glycolylneuraminic acid, Int. Arch. Allergy Appl. Immunol.
57 (1978) 477^480.
[15] Y. Fujii, H. Higashi, K. Ikuta, S. Kato, M. Naiki, Speci¢cities of
human heterophilic Hanganutziu and Deicher (H-D) and avian anti-
sera against H-D antigen-active glycosphingolipids, Mol. Immunol.
19 (1982) 87^94.
[16] L.K. Mahal, K.J. Yarema, C.R. Bertozzi, Engineering chemical re-
activity on cell surfaces through oligosaccharide biosynthesis, Science
276 (1997) 1125^1128.
[17] H. Kayser, R. Zeitler, C. Kannicht, D. Grunow, R. Nuck, W. Reut-
ter, Biosynthesis of a nonphysiological sialic acid in di¡erent rat
organs using N-propanoyl-D-hexosamines as precursors, J. Biol.
Chem. 267 (1992) 16934^16938.
[18] U. Schumacher, D. Mukhtar, P. Stehling, W. Reutter, Is the lectin
binding pattern of human breast and colon cancer cells in£uenced by
modulators of sialic acid metabolism?, Histochem. Cell Biol. 106
(1996) 599^604.
[19] M. Herrmann, C.W. von der Lieth, P. Stehling, W. Reutter, M.
Pawlita, Consequences of a subtle sialic acid modi¢cation on the
murine polyomavirus receptor, J. Virol. 71 (1997) 5922^5931.
[20] B.E. Collins, T.J. Fralich, S. Itonori, Y. Ichikawa, R.L. Schnaar,
Conversion of cellular sialic acid expression from N-acetyl- to N-
glycolylneuraminic acid using a synthetic precursor, N-glycolylman-
nosamine pentaacetate: inhibition of myelin-associated glycoprotein
binding to neural cells, Glycobiology 10 (2000) 11^20.
[21] K.J. Yarema, L.K. Mahal, R.E. Bruehl, E.C. Rodriguez, C.R. Ber-
tozzi, Metabolic delivery of ketone groups to sialic acid residues.
Application to cell surface glycoform engineering, J. Biol. Chem.
273 (1998) 31168^31179.
[22] G.A. Lemieux, K.J. Yarema, C.L. Jacobs, C.R. Bertozzi, Exploiting
di¡erences in sialoside expression for selective targeting of MRI con-
trast agents, J. Am. Chem. Soc. 121 (1999) 4278^4279.
[23] K. Jurianz, S. Ziegler, H. Garcia-Schu«ler, S. Kraus, O. Bohana-Kash-
tan, Z. Fishelson, M. Kirse¢nk, Complement resistance of tumor
cells : basal and induced mechanisms, Mol. Immunol. 36 (1999)
929^939.
[24] D.E. Speiser, R. Miranda, A. Zakarian, M.F. Bachmann, K. McKall-
Faizienza, B. Odermatt, D. Hanahan, R.M. Zinkernagel, P.S. Oha-
shi, Self antigens expressed by solid tumors do not e⁄ciently stim-
ulate naive or activated T cells : Implications for immunotherapy,
J. Exp. Med. 186 (1997) 645^653.
[25] G.D. MacLean, M.A. Reddish, M.B. Bowen-Yacyshyn, S. Poppema,
B.M. Longenecker, Active speci¢c immunotherapy against adenocar-
cinomas, Cancer Invest. 12 (1994) 46^56.
[26] V. Apostolopoulos, I.F.C. McKenzie, Cellular mucins: targets for
immunotherapy, Crit. Rev. Immunol. 14 (1994) 293^309.
[27] P.O. Livingston, Approaches to augmenting the immunogenicity of
melanoma gangliosides: from whole melanoma cells to ganglioside-
KLH conjugate vaccines, Immunol. Rev. 145 (1995) 147^166.
[28] S.J. Danishefsky, J.R. Allen, From the laboratory to the clinic : a
retrospective on fully synthetic carbohydrate-based anti-cancer vac-
cines, Angew. Chem. Int. Ed. Engl. 39 (2000) 836^863.
[29] F. Helling, A. Shang, M. Calves, S. Zhang, S. Ren, R.K. Yu, H.F.
Oettgen, P.O. Livingston, GD3 vaccines for melanoma: superior im-
munogenicity of keyhole limpet hemocyanin vaccines, Cancer Res. 54
(1994) 197^203.
[30] S. Capello, N.X. Liu, C. Musselli, F.-T. Brezicka, P.O. Livingston,
G. Ragupathi, Immunization of mice with fucosyl-GM1 conjugated
with keyhole limpet hemocyanin results in antibodies against human
small-cell lung cancer cells, Cancer Immunol. Immunother. 48 (1999)
483^492.
[31] R.A. Pon, M. Lussier, Q.-L. Yang, H.J. Jennings, N-Propionylated
group B meningococcal polysaccharide mimics a unique bactericidal
capsular epitope in group B Neisseria meningitidis, J. Exp. Med. 185
(1997) 1929^1938.
[32] H.J. Jennings, R. Roy, A. Gamian, Induction of meningococcal
group B polysaccharide speci¢c IgG antibodies in mice by using an
N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine,
J. Immunol. 137 (1986) 1708^1713.
[33] G. Ritter, E. Boosfeld, R. Adluri, M. Calves, H.F. Oettgen, L.J. Old,
P. Livingston, Antibody response to immunization with ganglioside
GD3 and GD3 congeners (lactones, amide, and gangliosidol) in pa-
tients with malignant melanoma, Int. J. Cancer 48 (1991) 379^385.
[34] G. Ritter, E. Boosfeld, M.J. Calves, H.F. Oettgen, L.J. Old, P.O.
Livingston, Antibody response to immunization with puri¢ed GD3
ganglioside and GD3 derivatives (lactones, amide and gangliosidol)
in the mouse, Immunobiology 182 (1990) 32^43.
[35] R. Roy, C.A. Laferrie're, A. Gamian, H.J. Jennings, N-Acetylneura-
CHBIOL 73 5-4-01 Cyaan Magenta Geel Zwart
274 Chemistry & Biology 8/3 (2001) 265^275
minic acid: neoglycoproteins and pseudopolysaccharides, J. Carbo-
hydr. Chem. 6 (1987) 161^165.
[36] P.D. Hodgkin, A. Basten, B-cell activation, tolerance, and antigen-
presenting function, Curr. Opin. Immunol. 7 (1995) 121^129.
[37] A. Rosenberg, Biology of the Sialic Acids, Plenum Press, New York,
1995.
[38] V. Piller, F. Piller, M. Fukuda, Biosynthesis of truncated O-glycans
in the T-cell line Jurkat. Localization of O-glycan initiation, J. Biol.
Chem. 265 (1990) 9264^9271.
[39] K.E. Norgard, K.L. Moore, S. Diaz, N.L. Stults, S. Ushiyama, R.P.
McEver, R.D. Cummings, A. Varki, Characterization of a speci¢c
ligand for P-selectin on myeloid cells. A minor glycoprotein with
sialylated O-linked oligosaccharides, J. Biol. Chem. 268 (1993)
12764^12774.
[40] O.T. Keppler, P. Stehling, M. Herrmann, H. Kayser, D. Grunow, W.
Reutter, M. Pawlita, Biosynthetic modulation of sialic acid-depen-
dent virus-receptor interactions of two primate polyoma viruses,
J. Biol. Chem. 270 (1995) 1308^1314.
[41] J. Kapuscinski, DAPI: a DNA-speci¢c £uorescent probe, Biotech.
Histochem. 70 (1995) 220^230.
[42] K. Rother, G.O. Till, G.M. Haensch, The Complement System,
Springer, Berlin, 1998.
[43] T. Liu, Z. Guo, Q. Yang, S. Sad, H.J. Jennings, Biochemical engi-
neering of surface K(2,8) polysialic acid for immunotargeting tumor
cells, J. Biol. Chem. 275 (2000) 32832^32836.
[44] R.B. Sashidhar, A.K. Capoor, D. Ramana, Quantitation of epsilon-
amino group using amino acids as reference standards by trinitroben-
zene sulfonic acid. A simple spectrophotometric method for the esti-
mation of hapten to carrier protein ratio, J. Immunol. Methods 167
(1994) 121^127.
CHBIOL 73 5-4-01 Cyaan Magenta Geel Zwart
Research Paper Induction of unnatural carbohydrate antigens G.A. Lemieux, C.R. Bertozzi 275
